Novo lost their patent protection for semaglutide in Canada because they failed to pay the maintenance fee. Oopsies.
Science.org | In the Pipeline | Novo Nordisk’s Canadian Mistake
Novo lost their patent protection for semaglutide in Canada because they failed to pay the maintenance fee. Oopsies.
Science.org | In the Pipeline | Novo Nordisk’s Canadian Mistake